Daniel P. Barrett, MD
Accepting new patients
“I try and think of my patients as family, and I hope my patients think of me as family.”
Dr. Barrett sees all ages and provides a variety of care and treatments in the tradition of a family physician and has a special interest in dermatology.
Language(s) - English
Growing up with a nurse mother and a physician step-father – along with a love of biology – partly guided Dr. Barrett’s path into medicine. “I also enjoy helping people,” he said.“That’s the answer I gave when I was asked why I wanted to be a doctor. It’s the same now.”
He prides himself on being friendly and accommodating. “I enjoy my interactions with patients and the relationship I have with them. That’s what makes my job satisfying. If it were any other way, I don’t think I would enjoy it.”
A native Oregonian who earned his undergraduate degree from Oregon State University, Dr. Barrett and his wife have five grown children. He enjoys hiking, camping, and both road and mountain biking.
McKay-Dee Family Practice, Ogden, UT, 1996
Doctor of Medicine, Oregon Health and Science University, Portland, OR, 1993; Bachelor of Science, Oregon State University, Corvallis, 1988
The Corvallis Clinic, 2001-Present; River Road Medical, Eugene, OR, 1998-2001; Oregon Medical Group, Eugene, OR, 1996-1998
American Board of Family Medicine
•D5881C00004 – A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk Patients with Hypertriglyceridemia (STRENGTH). Dec. 2014
•A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinoconjunctivitis With or Without Asthma. March 2013
•A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Grass (Phleum pratense) Sublingual Tablet (SCH 697243) in Subjects Between 5 and 65 Years of Age, With a History of Grass Pollen-Induced Rhinoconjunctivitis, With or Without Asthma. July 2011
•A Double-Blind, Randomized, Parallel, Placebo-Controlled, Multicenter Study Evaluating the Effect of Treatment with Topically Administered Oxybutynin Gel in Patients with Urinary Frequency, and Urge and Mixed Urinary Incontinence with a Predominance of Urge Incontinence Episodes. April 2009
•Safety and Efficacy of Exenatide in Patients with Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin. Eli Lilly, Sept. 2008
•A Randomized, multi-center, double-blind, parallel-group study of acetaminophen or fluvastin compared to placebo on transient Post-Dose Symptoms (PDS) following an intravenous infusion of a single dose of zoledronic acid, 5 mg, in post-menopausal women with low bone mass. Protocol CZOL446HUS136; Novartis Pharmaceuticals. June 2007
•A Randomized, Double-blind, Parallel-group, Multi-center Study to Compare Clinical Health Outcomes of Telithromycin versus Azithromycin in Outpatients with Community-Acquired Lower Respiratory Tract Infections. Protocol HMR3647A4019; Aventis Pharmaceuticals, Project Director, Manish Patel, MD. December 2005
•Clinical Investigator Training, The Corvallis Clinic, P.C., Corvallis, OR. December 2005
•Sub Investigator on multiple clinical research projects with River Road Medical Group, Eugene, OR. 1998 – 2001
Click on the appropriate link below to enter your provider’s telemedicine waiting room for your scheduled appointment.